JPS60108753A - Multilayer chemical analysis element - Google Patents

Multilayer chemical analysis element

Info

Publication number
JPS60108753A
JPS60108753A JP58217428A JP21742883A JPS60108753A JP S60108753 A JPS60108753 A JP S60108753A JP 58217428 A JP58217428 A JP 58217428A JP 21742883 A JP21742883 A JP 21742883A JP S60108753 A JPS60108753 A JP S60108753A
Authority
JP
Japan
Prior art keywords
layer
oxidase
titanium dioxide
reagent layer
reagent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP58217428A
Other languages
Japanese (ja)
Inventor
Fumitada Arai
文規 新井
Kenichiro Yazawa
矢沢 建一郎
Shunkai Katsuyama
春海 勝山
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujifilm Holdings Corp
Original Assignee
Fuji Photo Film Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fuji Photo Film Co Ltd filed Critical Fuji Photo Film Co Ltd
Priority to JP58217428A priority Critical patent/JPS60108753A/en
Priority to DE8484113978T priority patent/DE3485856T2/en
Priority to EP84113978A priority patent/EP0142849B1/en
Publication of JPS60108753A publication Critical patent/JPS60108753A/en
Priority to US07/011,386 priority patent/US4781890A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/26Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N31/00Investigating or analysing non-biological materials by the use of the chemical methods specified in the subgroup; Apparatus specially adapted for such methods
    • G01N31/22Investigating or analysing non-biological materials by the use of the chemical methods specified in the subgroup; Apparatus specially adapted for such methods using chemical indicators
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/52Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
    • G01N33/525Multi-layer analytical elements
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/805Test papers
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/14Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/142222Hetero-O [e.g., ascorbic acid, etc.]
    • Y10T436/143333Saccharide [e.g., DNA, etc.]
    • Y10T436/144444Glucose
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/25Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/25125Digestion or removing interfering materials

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

PURPOSE:To enhance accuracy in analysis, by including the fine powder of titanium dioxide, which has not undergone specified surface treatment, in a light shielding layer on a reagent layer, thereby eliminating errors caused by the interfering action of a fluoride. CONSTITUTION:A reagent layer, a light shielding layer, and a porous developing layer are provided in this order on a supporting body having water impermeability and light transmitting property such as a transparent polymer sheet characterized by poor hydrophilic property such as cellulose acetate. The reagent layer is prepared by including a hydrogen peroxide indicator, which yields the change that can be detected under the presence of peroxidase and hydrogen peroxide, peroxidase, and oxidase in a polymer binder. The fine powder of titanium dioxide, which has not undergone surface treatment including aluminum oxide or the hydrated oxide of aluminum, or the fine powder of titanium dioxide, which has not undergone surface treatment, is included in the light shielding layer characterized by oxygen permeability and protein impermeability on the reagent layer. Thus interference by fluoride can be eliminated.

Description

【発明の詳細な説明】 [産業上の利用分野J 本発明は多層化学分析費、もに関するもので、 、iT
しくは生物液体、特に保恒剤として弗化物が含イjされ
る血液試料(全面、血漿または血清)において弗化物に
よる被検物質の定IIi分析の妨、す(または干渉)が
排除された多層化学分析要素に関するものである。
[Detailed description of the invention] [Industrial field of application J] The present invention relates to multilayer chemical analysis,
or in biological fluids, especially blood samples (whole surface, plasma or serum) containing fluoride as a preservative, the interference (or interference) of fluoride with the standard IIi analysis of the analyte has been eliminated. It concerns multilayer chemical analysis elements.

[従来技術] 血液試料(以下、特にことわらない限り全面、血漿およ
び面枯いずれをも意味する)に保恒剤として弗化物、例
えば弗化ナトリウム、弗化リチウム等を添加することが
広く行われている。弗化物は検値作用としての面液凝固
防11、作用のほかに解糖阻止作用をもイ1するので、
ことに血液中のブドウil+含有ね1の測定に際し血液
試料への添加に適している。(金井泉 原著、金井正光
 編!A「臨床検査〃:提要」改訂291医(金属出版
、1983年発行)228頁、 R,D、Henry、
 D、C,Cannon、 J、W、Winke1ma
n編X rclinical Chemistry P
r1nciples and TechnicsJ 2
nd Ed、 (Harper & Row、 Pub
lishers、 1974年発行) 385−388
頁等参照)保恒剤としての弗化物は、血液採取後直ちに
血液に添加するか、または弗化物を内面に塗布した採決
管に血液を採取することにより血液に添加ごれるのが一
般的である。弗化物は、例えばNaFの場合、血液試料
1m文当り約1mgから約10mgの範囲で含有される
ことが多い。近年隆盛になった酵素、特にオキシダーゼ
(例、グルコースオキシダーゼ、コレステロールオキシ
ダーゼ等)を含む試薬系で分析する方法において、弗素
陰イオンは被検物質含有量を低値にする負誤差を与える
妨害作用(または干渉作用)を有することが判明してい
る。ことに弗化物が多肢に含有される血液試ネ:1を用
いて分析する場合、および弗化物が含有される血液試才
1を乾式陛角の多層分析要素に適用して分析する場合に
、弗7も陰イオンに起因する負誤差か著しいので、負コ
’+Xの解消か屯黄な技ソート【的課題になっている。
[Prior Art] It is widely practiced to add fluoride, such as sodium fluoride, lithium fluoride, etc., as a preservative to a blood sample (hereinafter referred to as whole surface, plasma, or dead surface unless otherwise specified). It is being said. In addition to its anticoagulant effect on surface fluid11 as a value checking effect, fluoride also has a glycolysis inhibiting effect11, so
It is particularly suitable for addition to a blood sample when measuring grape il+-containing blood in blood. (Original author by Izumi Kanai, edited by Masamitsu Kanai! A “Clinical Examination: Summary” Revised 291 Doctors (Metal Publishing, published in 1983) 228 pages, R, D, Henry,
D, C, Cannon, J, W, Winke1ma
Part nX Clinical Chemistry P
r1nciples and TechnicsJ 2
nd Ed, (Harper & Row, Pub
lishers, published in 1974) 385-388
(See pages, etc.) Fluoride as a preservative is generally added to blood immediately after blood collection, or by collecting blood into a blood sampling tube coated with fluoride. be. Fluoride, for example in the case of NaF, is often contained in a range of about 1 mg to about 10 mg per 1 m blood sample. In methods that use reagent systems containing enzymes, especially oxidases (e.g., glucose oxidase, cholesterol oxidase, etc.), which have become popular in recent years, fluorine anions have an interfering effect that causes negative errors that lower the content of the test substance ( or interference effects). Particularly when performing an analysis using a blood test sample 1 containing fluoride, and when applying a blood test sample 1 containing fluoride to a multilayer analysis element of a dry majestic horn. , 弗7 also has a significant negative error caused by anions, so solving the negative ko'+X is a serious problem.

弗化物による負誤差を解消するために、特公昭57−2
827753に記載のグルコース定jt目11体型多層
分析要素においては、グルコースオキシダーゼ、ペルオ
キシダーゼ、4−アミノアンチピリンおよび7−ヒドロ
キシ−1−十71・−ルを含むグルコースA11l定試
薬Ml成物を含む試薬層に、使用条件(分析条ヂ1)ド
においてp H(fiを5.0ないし5.6にM[持す
るpH緩村「I剤または有機耐として、3,3−ジメチ
ルグルタル酸、こは〈酎またはりんご酸を含有させるこ
とが提案されている。また特願昭57−131750号
に記載の多層分析要素においては、弗化物による負誤X
−を解消するためにグルコースオキシダーゼまたはコレ
ステロールオキシダーゼ等のオキシダーゼ、ペルオキシ
ダーゼ、4−アミノアンチピリン、1.7−シヒドロキ
シナフタレンを含むグルコースまたはコレステロール分
析用試薬組成物に、弗素陰イオ/との間に水に難溶性の
塩を形成しうるカルシウム陽イオン等を含む酢酸カルシ
ウム等を併用することか提案されている。ところが、こ
れらの技術を適用したグルコース定量分析用多層分析要
素において、従来から用いられていた酸化アルミニウム
またはアルミニウムの含水酸化物を含む物質で表面処理
された二酸化チタン微粉末を含有する光遮蔽層または光
反射層を設けた場合に、依然として弗化物に起因する負
誤差が生じるばかりでなく、酢酸カルシウム等を併用し
たグルコース定量分析用多層分析要素においては、弗化
物含有量が少ない範囲では弗化物に起因する正誤差が生
じ、弗化吻合41量が多い範囲では、弗化物に起因する
負誤差が生ずるという弗化物に起因する複雑な妨害作用
(または干渉作用)が現れることが見い出された。
In order to eliminate the negative error caused by fluoride,
827753, a reagent layer containing a glucose A111 reagent M1 composition containing glucose oxidase, peroxidase, 4-aminoantipyrine, and 7-hydroxy-1-171. In addition, under the conditions of use (analytical conditions 1), 3,3-dimethylglutaric acid, 3,3-dimethylglutaric acid, (It has been proposed to contain chuu or malic acid. Also, in the multilayer analytical element described in Japanese Patent Application No. 131750/1989, negative error X due to fluoride has been proposed.
In order to eliminate the It has been proposed to use calcium acetate or the like containing calcium cations that can form poorly soluble salts. However, in multilayer analytical elements for glucose quantitative analysis to which these technologies are applied, a light shielding layer containing fine titanium dioxide powder whose surface is treated with a substance containing aluminum oxide or a hydrous oxide of aluminum, which has been conventionally used, or When a light reflective layer is provided, not only does a negative error still occur due to fluoride, but in a multilayer analytical element for glucose quantitative analysis that uses calcium acetate etc. It has been found that in a range where a positive error due to fluoride occurs and the amount of fluoride anastomosis 41 is large, a complex interference effect (or interference effect) due to fluoride appears in which a negative error due to fluoride occurs.

[発明の目的] 本発明の目的は、オキシダーゼ、ペルオキシダーゼ、水
素供与体(色原体)、およびカプラー(または水素供り
°体とカプラーのM1合せのかわりに、酸化により発色
または変色する?ロー化合物である水素供ケ1体)を含
む弔−または複数の試薬層、二酸化チタン微粉末を含む
光遮蔽層(または光反射層)、および多孔性展開層を有
する多層化学分析要素において、血液試Flに含有され
る弗化物による妨害作用(または1°渉作用)の結果と
して生ずる負誤差または1.7′l差を解消して分析精
度を高めることであり、さらに多層化学分析要素内の試
薬層に代表される副層の分析条件下におけるPH値を意
図した(fiに維持することにより分析精度を高めるこ
とにもある。
[Objective of the Invention] The object of the present invention is to use an oxidase, a peroxidase, a hydrogen donor (chromogen), and a coupler (or a chromogen that develops or changes color by oxidation instead of the M1 combination of the hydrogen donor and the coupler). A multilayer chemical analysis element having one or more reagent layers containing a hydrogen donor compound (a hydrogen donor compound), a light shielding layer (or a light reflection layer) containing fine titanium dioxide powder, and a porous spreading layer. The objective is to eliminate the negative error or 1.7′l difference that occurs as a result of the interfering effect (or 1° interfering effect) due to the fluoride contained in Fl, and to improve the analytical precision by eliminating the It is also possible to improve the accuracy of analysis by maintaining the PH value under the analysis conditions of the sublayer represented by the layer to the intended value (fi).

[発明の構成] 前記の目的は多層化パフ゛分析要素において、光遮蔽層
(または光反射層)に含有される一m化チタン微粉末と
して酸化アルミニウド(アルミナ)またはアルミニウム
の含水酸化物を(アルミナ永和物等)を含む物質で表面
処理されていない二酸化チタン微粉末または表面処理さ
れていない二酸化チタン微粉末を用いることにより達成
される。
[Structure of the Invention] The above object is to use aluminum oxide (alumina) or a hydrous oxide of aluminum (aluminum oxide) as a fine titanium oxide powder contained in a light shielding layer (or light reflection layer) in a multilayered powder analytical element. This can be achieved by using fine titanium dioxide powder that has not been surface-treated with a substance containing a chemical compound (e.g., permanent compound) or fine titanium dioxide powder that has not been surface-treated.

本発明は、水不透過性光透過性支持体の上に試薬層、光
遮蔽層、および多孔性展開層がこの順に設けられてなる
多層化学分析要素において、IMf記光遮光遮蔽層化ア
ルミニウムまたはアルミニウムの含水酸化物を含む物質
による表面処理がなされていない−m化チタン微粉末ま
たは表面処理されていない二酸化チタン微粉末が含有さ
れている多層化学分析要素である。
The present invention provides a multilayer chemical analysis element in which a reagent layer, a light-shielding layer, and a porous development layer are provided in this order on a water-impermeable, light-transmitting support, in which IMf light-shielding layered aluminum or This is a multilayer chemical analysis element containing fine titanium oxide powder or fine titanium dioxide powder that has not been surface-treated with a substance containing a hydrous oxide of aluminum.

本発明に用いることができろ水不浸透性光透過性支持体
としては、特公昭53−21677号、特開昭55−1
64356号等の明細書に記載の多層分4fr要Jの支
持体に用いられているものから適宜に選択して用いるこ
とができる。支持体の具体例としては、酢酸セルロース
、酢酸酩酊セルロース、ポリ(エチレンテレフタレート
)、ビスフェノールAのポリカルボネート、ポリスチレ
ン、ポリメチルメタクリレートなどの親水性にとぼしい
かまたは疎水性のポリマーで、約50JLmから約1m
m、好ましくは約801Lmから約400gmの範囲の
厚さの透明なフィルムまたはシート、および厚さ約10
0gmから約2mm、&/ましくは約150gmから約
1mmの範囲の透明なカラス板などをあげることができ
る。支持体の表面は必要により公知の物理化学的処理(
例、紫外線!+(!射、コロナ放電処理、グロー放電処
理等)を実施して試薬層重との接11力を高めるか、あ
るいは物理化学的処理を施して(または、施さずに)親
水性ポリマーであるゼラチン等のド塗り層を設けて試薬
層等との接71力を高めることができる。
Examples of the water-impermeable, light-transmitting support that can be used in the present invention include Japanese Patent Publication No. 53-21677 and Japanese Patent Application Laid-Open No. 55-1
It can be appropriately selected and used from those used in multilayer 4fr J supports described in specifications such as No. 64356. Examples of supports include less hydrophilic or hydrophobic polymers such as cellulose acetate, cellulose acetate, poly(ethylene terephthalate), polycarbonate of bisphenol A, polystyrene, polymethyl methacrylate, etc. from about 50 JLm. Approximately 1m
m, preferably a transparent film or sheet with a thickness ranging from about 801 Lm to about 400 gm, and a thickness of about 10 gm.
Examples include transparent glass plates having a thickness ranging from 0 gm to about 2 mm, and/or preferably from about 150 gm to about 1 mm. The surface of the support may be subjected to known physicochemical treatment (
For example, ultraviolet rays! Hydrophilic polymers are subjected to (irradiation, corona discharge treatment, glow discharge treatment, etc.) to increase the contact force with the reagent layer, or to physicochemical treatment (or without). A coating layer of gelatin or the like can be provided to increase the contact force with the reagent layer and the like.

試薬層はペルオキシダーゼと過酷化水素との存在下で検
出IIT能な変化を生ずる過酸化水素指示薬、ペルオキ
シダーゼ、およびオキシダーゼが親水性の被膜形成f市
を有するポリマーバインターの中に分散または溶解して
含有される層である。後述するように、オキシダーゼ層
を別個の層として設け、そこにオキシダーゼを含有させ
ることもできるほか、試薬層とオキシダーゼ層の両層に
オキシダーゼを含有させることもできる。過酸化水素指
示薬としては、rAnnales of C11nic
al Chemistry J 、6.24−27(1
989)、米国41fa第3992158号、特公昭5
5−25840号、特公昭56−45599号、特公昭
58−18628号、特願昭57−165233号等に
記載の水素供ケ一体(色原体)とフェノールまたはナフ
トール系カプラーとの組合せ、特公昭57−5519号
、特願昭58−68009号等に記載のトリアリールイ
ミダツール系ロイコ色素、特公昭56−45599号、
特公昭58−18628号等に記載の単一の化合物でペ
ルオキシダーゼと過酸化水素との存在rで自己カプリン
グ等により発色または変色する色素前駆体化合物等を用
いることができる。好ましい過酸化水素指示薬の例とし
て次の化合物がある。
The reagent layer comprises a hydrogen peroxide indicator, peroxidase, and oxidase dispersed or dissolved in a polymeric binder having a hydrophilic film-forming surface that produces a detectable change in the presence of peroxidase and hydrogen. This is the layer that is included. As described below, the oxidase layer can be provided as a separate layer and contain oxidase, or both the reagent layer and the oxidase layer can contain oxidase. As a hydrogen peroxide indicator, rAnnales of C11nic
al Chemistry J, 6.24-27(1
989), U.S. 41FA No. 3992158, Special Publication No. 5
5-25840, Japanese Patent Publication No. 56-45599, Japanese Patent Publication No. 58-18628, Japanese Patent Application No. 57-165233, etc., combinations of hydrogen donor monomers (chromogens) and phenol or naphthol couplers, Triaryl imidatool-based leuco dyes described in Japanese Publication No. 57-5519, Japanese Patent Application No. 58-68009, etc., Japanese Patent Publication No. 56-45599,
It is possible to use a dye precursor compound described in Japanese Patent Publication No. 58-18628, etc., which is a single compound and develops or changes color by self-coupling in the presence of peroxidase and hydrogen peroxide. Examples of preferred hydrogen peroxide indicators include the following compounds.

水素供与体(色原体)とカプラーとの組合せ:[水素供
与体]4−アミノアンチピリン、4−アミノ−2−メチ
ル−3−フェニル−1−(2゜4.6−)リクロロフェ
ニル)−3−ピラゾリン−5−オン等の4−アミンアン
チピリンホモログまたは誘導体 [カプラー] 1.7−シヒドロキシナフタレン、■−
ヒドロキシナフタレンー2−スルホン酸ナトリウム(ま
たはカリウム)等の1−ヒドロキシナフタレン誘導体 トリアリールイミダゾール系ロイコ色素:4.5−ビス
[4−(ジメチルアミノ)フェニル] −2−(4−ヒ
ドロキシ−3,5−ジメトキシフェニル)イミダゾール
、4−(ジメチルアミノ)フェニル−2−(4−ヒドロ
キシ−3,5−ジメトキシフェニル)−5−フェネチル
イミダゾール等 色素前駆体化合物;ジアニシジン、4−7トキシー1−
ナフトール等 ペルオキシダーゼとしては特公昭56−45599号、
特公昭57−5520 k:等に記載の植物起源および
動物起源のペルオキシダーゼ(EC1,11,1,7)
、特公昭58−5035号等に記載の微生物起源のペル
オキシダーゼ(EC1,11,1,7)を用いることが
できる。これらのうちでは植物起源または微生物起源の
非特異的ペルオキシダーゼが好ましい。好ましいベルオ
ギシターゼの例として、西洋わさびペルオキシダーゼ(
最適pH約7 、0) 、だいこんペルオキシダーゼ、
Cochliobolus m1yabeanusペル
オキシダーゼ(最適pH5、0〜5 、3) 、Pe1
licularia filamentosaペルオキ
シダーゼ(最1apH4,7〜4.9)等がある。
Combination of hydrogen donor (chromogen) and coupler: [Hydrogen donor] 4-aminoantipyrine, 4-amino-2-methyl-3-phenyl-1-(2°4.6-)lichlorophenyl)- 4-amine antipyrine homologues or derivatives such as 3-pyrazolin-5-one [couplers] 1.7-hydroxynaphthalene, ■-
1-hydroxynaphthalene derivatives such as sodium (or potassium) hydroxynaphthalene-2-sulfonate Triarylimidazole leuco dye: 4.5-bis[4-(dimethylamino)phenyl]-2-(4-hydroxy-3, Dye precursor compounds such as 5-dimethoxyphenyl)imidazole, 4-(dimethylamino)phenyl-2-(4-hydroxy-3,5-dimethoxyphenyl)-5-phenethylimidazole; dianisidine, 4-7toxy-1-
As peroxidase such as naphthol, Japanese Patent Publication No. 56-45599,
Peroxidases of plant and animal origin (EC1, 11, 1, 7) described in Japanese Patent Publication No. 57-5520 K: et al.
Peroxidase of microbial origin (EC1, 11, 1, 7) described in Japanese Patent Publication No. 58-5035, etc. can be used. Among these, non-specific peroxidases of plant or microbial origin are preferred. An example of a preferred peroxidase is horseradish peroxidase (
Optimum pH about 7,0), radish peroxidase,
Cochliobolus mlyabeanus peroxidase (optimum pH 5, 0-5, 3), Pe1
licularia filamentosa peroxidase (maximum pH 4.7 to 4.9) and the like.

オキシダーゼは、被検物質を酸素(02)により酸化し
てH2O2を生成させるオキシダーゼであればよい。オ
キシダーゼは被検物質に応じて選択することができる。
The oxidase may be any oxidase that oxidizes the test substance with oxygen (02) to generate H2O2. Oxidase can be selected depending on the test substance.

本発明において用いることかできるオキシダーゼの具体
例としては次のものがある。
Specific examples of oxidases that can be used in the present invention include the following.

グルコースオキシダーゼ (ECI 、 l 、3.4;最適pH約5.6)コレ
ステロールオキシダーゼ (EC1,1,3,6,最適pH約5.8)ウリカーセ
゛ (EC1,7,3,3;最ii!pH約7.5〜8.0
)サルコシンオキシダーゼ (EC1,5,3,1,最適pH約7.0〜8.0)ラ
クテートオキシダーゼ、ピルヘートオキシターゼ、グル
タメートオキシグーゼ、グリセロールオキシダーゼ、ビ
リルピンオキシダーゼ、等。
Glucose oxidase (ECI, l, 3.4; optimum pH approximately 5.6) Cholesterol oxidase (EC1, 1, 3, 6, optimum pH approximately 5.8) Uricase (ECI, 1, 3, 3; optimum pH approximately 5.6) Approximately 7.5-8.0
) Sarcosine oxidase (EC1,5,3,1, optimum pH about 7.0-8.0) lactate oxidase, pyruhate oxidase, glutamate oxidase, glycerol oxidase, bilirupine oxidase, etc.

この他にも特開昭53−24893吟、特公昭56−4
5599号、特開It/157−208998号、特願
昭57−165233弓等に記4乱のオキシダーゼまた
はオキシダーゼを含む複数種の酵素の組合せを用いるこ
とができる。必要に応じてオキシダーゼとともに補因子
および/または補酵素を組合せて用いることができる。
In addition to this, there is also JP-A-53-24893 Gin, JP-A-56-4.
5599, Japanese Patent Application Laid-open No. 157-208998, Japanese Patent Application No. 57-165233, etc., oxidases or combinations of multiple types of enzymes containing oxidases can be used. Cofactors and/or coenzymes can be used in combination with oxidase as needed.

試薬層に用いられる親木性ポリマーバインダーとしては
特公昭53−21677吟、特公昭56−45599号
、特公昭57−5519号、特開昭55−164356
号、特開昭57−208997号等に記載の多層分析要
素の試薬層の親木性ポリマーバインダーとして用いられ
ている公知の親木性ポリマーから適宜に選択して用いる
ことができる。親水性ポリマーの例としてはゼラチン(
例、酸処理ゼラチン、脱イオン化ゼラチンT)、ゼラチ
ン、誘導体(例、フタル化ゼラチン。
As the wood-philic polymer binder used in the reagent layer, Japanese Patent Publication No. 53-21677 Gin, Japanese Patent Publication No. 45599-1988, Japanese Patent Publication No. 5519-1987, and Japanese Patent Publication No. 164356-1983 are used.
The binder can be appropriately selected from known wood-philic polymers used as wood-philic polymer binders in the reagent layer of multilayer analytical elements described in Japanese Patent Application Laid-Open No. 57-208997. An example of a hydrophilic polymer is gelatin (
e.g., acid-treated gelatin, deionized gelatin T), gelatin, derivatives (e.g., phthalated gelatin).

ヒドロキシメチルアクリレートグラフト化ゼラチン等)
、プルラン、プルラン誘導体、アガロ〜ス、ボリビこル
アルコール、ポリビニルピロリドン、ポリアクリルアミ
ド等がある。これらのうちではゼラチンか一般的で、か
つ好ましい。
hydroxymethyl acrylate grafted gelatin, etc.)
, pullulan, pullulan derivatives, agarose, boribicol alcohol, polyvinylpyrrolidone, polyacrylamide, and the like. Among these, gelatin is common and preferred.

試薬層の乾燥厚さは約5#Lmから約60jLm、好ま
しくは約10JLmから約30pLmの範囲である。ペ
ルオキシダーゼの試薬層における含有、rij、は約5
千U/ mIから約lO万U/m″、好ましくは約1刀
U / m′から約6万U/rri’の範囲である。試
薬層におけるオキシダーゼの含有量はオキシダーゼの種
類により異なるが、概して約1千0/m’から約10万
U / m’、好ましくは約3千U/rn’から約5万
tJ/rn’の範囲である。グルコースオキシダーゼの
場合には含*量は約2千0 / m”から約4万U/ 
me、好ましくは約4千U / m”から約3万TJ 
/ m’の範囲である。過酸化水素指示薬の指示薬層に
おける含有量は水性液体試料に含有される被検成分の予
想される含有量に応じて適宜定めることができる。
The dry thickness of the reagent layer ranges from about 5 #Lm to about 60JLm, preferably from about 10JLm to about 30 pLm. The content of peroxidase in the reagent layer, rij, is approximately 5
The range is from 1,000 U/mI to about 10,000 U/m'', preferably from about 1 U/m' to about 60,000 U/rri'. The content of oxidase in the reagent layer varies depending on the type of oxidase, It generally ranges from about 1,000/m' to about 100,000 U/m', preferably from about 3,000 U/rn' to about 50,000 tJ/rn'.In the case of glucose oxidase, the content is about 2,000/m” to approximately 40,000 U/m”
me, preferably about 4,000 U/m” to about 30,000 TJ
/m' range. The content of the hydrogen peroxide indicator in the indicator layer can be determined as appropriate depending on the expected content of the test component contained in the aqueous liquid sample.

本発明の態様として、試薬層に過酸化水素指示薬とペル
オキシダーゼを含有させ、試薬層の」:側(試薬層に関
して支持体とは反対側、すなわち支持体から遠い側)に
オキシダーゼを含有するオキシダーゼ層を設けたm;様
、およびオキシダーゼを、後述する多孔性IJ(間層、
定面積多孔性層、接着層、光遮蔽層のいずれかに含イ1
させる居、様がある。特開昭57−2089971;公
報に記・1配されているように、オキシダーゼを過酸化
水素指示薬とペルオキシダーゼを含む試薬層(以下、こ
の層を特に指示する場合には、指示薬層という)より上
側の層に含有させる態様は、オキシダーゼが触媒する基
質の反応に必要な空気中の酩素のオキシダーゼへの効率
的な拡散による輸送等により、オキシダーゼが触媒する
酸化反応の進行が円滑・迅速に進行して、発色の高効イ
l化、または分析時間の短縮化がもたされるので、本発
明の好ましい態様の一つである。オキシダーゼを試薬層
の」−側の層に含有させる場合のオキシダーゼの含有値
は前述の含有ダと同じでよい、オキシダーゼ層は指示薬
層の」−に直接または後述の中間層を介して設けること
ができる。
As an embodiment of the present invention, the reagent layer contains a hydrogen peroxide indicator and peroxidase, and the oxidase layer contains oxidase on the ":" side of the reagent layer (the side opposite to the support with respect to the reagent layer, that is, the side far from the support). and oxidase were added to the porous IJ (interlayer,
Contained in either the constant area porous layer, adhesive layer, or light shielding layer 1
There is a certain way to make it happen. JP-A-57-2089971: As described and arranged in the publication, oxidase is placed above a reagent layer containing a hydrogen peroxide indicator and peroxidase (hereinafter, when this layer is specifically designated, it is referred to as an indicator layer). The mode of inclusion in the layer allows the oxidation reaction catalyzed by oxidase to proceed smoothly and quickly due to the efficient diffusion and transport of the airborne fluorine necessary for the oxidase-catalyzed substrate reaction to the oxidase. This is one of the preferred embodiments of the present invention because highly effective illumination of color development or shortening of analysis time can be achieved. When oxidase is contained in a layer on the side of the reagent layer, the content value of oxidase may be the same as the above-mentioned content, and the oxidase layer can be provided directly on the side of the indicator layer or via an intermediate layer described below. can.

試薬層にはオキシダーゼおよびペルオキシダーゼの最適
pHの近傍のPH値、または少なくとも両酵素の活性が
実質に阻害されず、かつ過酸化水素指示薬の発色(また
は変色)反応が円滑に速やかに進行する範囲のpH値、
すなわち分析条件下において試薬層のpH値を約4.0
から7.5、好ましくは約4.5から約7.0の範囲に
維持するpH緩衝剤を含有させることができる。オキシ
ダーゼ層を試薬層の上側に設けるか、またはオキシダー
ゼを試薬層の上側のいずれかの層に含有させる場合には
、オキシダーゼ層またはオキシダーゼを含有する層にオ
キシダーゼの最適PH値またはその近傍の値に維持する
緩衝剤を含有させ、指示薬層には、ペルオキシダーゼの
最適PH値またはその近傍の値に維持するかまたは少な
くともペルオキシダーゼの活性が実質的に阻害されず、
かつ過酸化水素指示薬の発色(または変色)反応が円滑
に速かに進行するpH値に維持するpHH衝剤を含有さ
せることができる。pH緩衝剤としては、rBioch
emistryJ 、5(2)、4B?−477(+9
1(6)、R。
The reagent layer contains a pH value close to the optimum pH of oxidase and peroxidase, or at least within a range in which the activities of both enzymes are not substantially inhibited and the color development (or color change) reaction of the hydrogen peroxide indicator proceeds smoothly and quickly. pH value,
That is, under the analysis conditions, the pH value of the reagent layer is approximately 4.0.
to 7.5, preferably from about 4.5 to about 7.0. When the oxidase layer is provided above the reagent layer, or when the oxidase is contained in any layer above the reagent layer, the oxidase layer or the layer containing oxidase is provided with a pH value at or near the optimum pH value for the oxidase. The indicator layer contains a buffer that maintains the peroxidase at or near the optimum pH value, or at least the activity of the peroxidase is not substantially inhibited.
In addition, a pHH buffer can be included to maintain the pH value at which the color development (or color change) reaction of the hydrogen peroxide indicator proceeds smoothly and quickly. As a pH buffer, rBioch
emistryJ, 5(2), 4B? -477 (+9
1(6), R.

M、C,Dawson et al、編rData f
or BiochemicalResearchJ第2
版(Oxford at the C1arendon
 PreSS、l968年発行)47G−508j:f
、、rAnalytical Biochemistr
yJ 、 104.300−310(1980)、口木
化学会編「化学便覧基礎編」 (東京、丸善、1866
年発行)1312−1320頁、日本生花゛l:会編[
生化学データブックIJ (東京化学同人、1979年
発行) 17−24頁、特公昭57−28277号等に
記載の公知のpH緩衝剤から適宜に選択して用いること
ができる。
Edited by M. C. Dawson et al.
or Biochemical Research J 2nd
Edition (Oxford at the C1arendon
PreSS, published in 1968) 47G-508j:f
,,rAnalytical Biochemistr
yJ, 104.300-310 (1980), “Basic Chemical Handbook” edited by Kuchiki Kagakukai (Tokyo, Maruzen, 1866)
Published in 2013) pp. 1312-1320, edited by Japanese Flower Association [
It can be appropriately selected and used from the known pH buffers described in Biochemical Data Book IJ (published by Tokyo Kagaku Dojin Co., Ltd., 1979), pages 17-24, Japanese Patent Publication No. 57-28277, and the like.

試薬層(またはオキシダーゼ層)の−1−に酸素透過性
蛋白質不透過性光遮蔽層(以下、巾に光遮蔽層というこ
とがある。)が、没けられる。酸素透過性蛋白質不透過
性とは、分析条件下に、すなわち水性液体試料または血
液試料の溶媒である水がこの層に侵透してこの層が混用
または膨潤しているときに、この層を空気中の酸素(o
2)は実質的に通過可能であり、一方正白質は実質的に
通過不【+7能であることを意味する。またここでいう
蛋白質とは分子−r、)約5千以上の適冷の意味での蛋
白質であり、特にはヘモグロビン(分子に約6万5丁)
に代表されるヘム蛋白質、カタラーゼ(分子、°、:約
25万)等の過醜化水素分解活性を有する複合蛋白質で
ある。酸素透過性蛋白質不透過性光遮蔽層は、光遮蔽性
および光反射性を有する二酸化チタン微粉末が少酸の被
膜形成能を有する親水性(または弱親水性)ポリマーバ
インダーに分散保持されている実質的に非孔性の層であ
る。光遮蔽層は、試薬層における発色または変色を光透
過性支持体側から反射測光する際に後述する展開層に点
着された血液試料の色、特に全血の場合のヘモグロビン
による赤色等を遮蔽し同時に光反射層および背景層とし
ても機能する。
An oxygen permeable and protein impermeable light shielding layer (hereinafter sometimes referred to as a light shielding layer) is submerged in -1- of the reagent layer (or oxidase layer). Oxygen-permeable and protein-impermeable means that this layer is not permeable under analytical conditions, i.e. when water, the solvent of an aqueous liquid sample or blood sample, penetrates this layer and causes the layer to mix or swell. Oxygen in the air (o
2) means that it is essentially transmissible, whereas the normal white matter is virtually transmissible. Also, protein here refers to protein in the sense of moderate cooling, which has molecules -r,) of about 5,000 or more, and especially hemoglobin (about 65,000 molecules).
It is a complex protein that has the activity of degrading hypermorphic hydrogen, such as heme proteins represented by , catalase (molecules, approximately 250,000 molecules), etc. The oxygen-permeable, protein-impermeable light-shielding layer is made up of fine titanium dioxide powder that has light-shielding and light-reflecting properties dispersed in a hydrophilic (or weakly hydrophilic) polymer binder that has the ability to form a film of oligoacid. It is a substantially non-porous layer. The light-shielding layer blocks the color of a blood sample spotted on the developing layer, which will be described later, when measuring color development or discoloration in the reagent layer by reflection photometry from the light-transmitting support side, especially the red color caused by hemoglobin in the case of whole blood. At the same time, it functions as a light-reflecting layer and a background layer.

光遮蔽層に用いられる二酸化チタン微粉末は酸化アルミ
ニウム(アルミナ、A4120g)またはアルミニウム
の含水酸化物(例、アルミナ水和物A文203IIH2
0、A立203・3)120等)笠の三価アルミニウム
と酎、シ、を含むアルミニウム化合物、または云モ価ア
ルミニウムと他の元、V。
The fine titanium dioxide powder used in the light shielding layer is aluminum oxide (alumina, A4120g) or hydrated oxide of aluminum (e.g., alumina hydrate A203IIH2).
0, A standing 203.3) 120 etc.) Aluminum compounds containing trivalent aluminum and shochu, shi, or valent aluminum and other bases, V.

(例、四価F1素)と酸ふを含む物質を用いた表面処理
(主として被va)がなされていない−酸化チタン微粉
末、または表面処理されていない二酸化チタン微粉末(
未明細、りではこれらの総称としてり1にアルミナ処理
なしの二酸化チタン微粉末という)である。二酸化チタ
ン微粉末はアナターゼ(Anatase)型、ルチル(
Rutile)型、またはプルカイト(Brookit
e)型いずれの結晶型でもよい。
Titanium oxide fine powder that has not been surface treated (mainly VA) with a substance containing (e.g., tetravalent F1 element) and acid sulfur, or titanium dioxide fine powder that has not been surface treated (
(Unspecified), these are collectively referred to as titanium dioxide fine powder without alumina treatment. Titanium dioxide fine powder is anatase type, rutile (
Rutile type, or Brookit type.
Type e) Any crystal type may be used.

微粉末の平均粒子サイズは市販品として人r−+r(能
な約0.1μmから約1.OILm、tl(ましく j
i約0.157zmから約0.5μmの範囲である。ア
ルミナ処理なしの二酸化チタン微粉末のJL体例として
、表面処理されていない一’[化チタン依粉末、水酸化
チタンで表面処理した一1醇化チタン微粉末、シリカ(
二酸化珪素)で表面処理した二酸化チタン微粉末等があ
り、これらのうちで表面処理されていない二酸化チタン
微粉末が好ましい。
The average particle size of the fine powder ranges from approximately 0.1 μm to approximately 1.0 μm as a commercially available product.
i ranges from about 0.157 zm to about 0.5 μm. JL examples of fine titanium dioxide powder without alumina treatment include 1'[titanium oxide powder without surface treatment, 11-dioxide titanium powder surface-treated with titanium hydroxide, and silica powder.
There are fine titanium dioxide powders surface-treated with silicon dioxide), and among these, fine titanium dioxide powders that are not surface-treated are preferred.

被膜形成能を有する親木性(または弱親水性)ポリマー
バインダーとしてはゼラチン(例、酸処理ゼラチン、脱
イオン化ゼラチン等)、ゼラチン誘導体(例、フタル化
ゼラチン、ヒドロキシメチルアクリレートグラフト化ゼ
ラチン等)、ポリビニルアルコール、再生セルロース、
セルロースアセテート(例、セルロースジアセテート)
等があり、これらのうちではゼラチン、ゼラチン誘導体
等が好ましい。ゼラチン、ゼラチン誘導体は公知の硬化
剤(架橋剤)とともに用いることができる。なお、後述
する接着層にこれらのポリマーを用いる場合には光遮蔽
層のポリマーバインダーとしては指示薬層に用いるのと
同様に広範囲の親木性ポリマーから選釈して用いること
ができる。
Examples of the wood-philic (or weakly hydrophilic) polymer binder having film-forming ability include gelatin (e.g., acid-treated gelatin, deionized gelatin, etc.), gelatin derivatives (e.g., phthalated gelatin, hydroxymethyl acrylate-grafted gelatin, etc.), polyvinyl alcohol, regenerated cellulose,
Cellulose acetate (e.g. cellulose diacetate)
Among these, gelatin, gelatin derivatives, etc. are preferred. Gelatin and gelatin derivatives can be used together with known hardening agents (crosslinking agents). In addition, when these polymers are used in the adhesive layer described later, the polymer binder of the light shielding layer can be selected from a wide range of wood-loving polymers as in the case of the indicator layer.

光遮蔽層におけるアルミナ処理なしの二酸化チタン微粉
末とポリマーバインダー(乾燥時)との比は、光遮蔽層
の酸素透過性が保たれ、かつ同時に蛋白不透過性が保た
れる程度に非孔性である(これは多孔性展開層における
展開作用またはメータリング作用が現れる平均孔サイズ
よりも小さく、展開作用またはメータリング作用を有し
ない程度の微孔+1をも包含する。)範囲で用いること
ができる。これは具体的には屯I11比でアルミナ処理
なしの二酸化チタン微粉末1oに対しポリマー/へイン
グー(乾燥屯!1;)約0.6から約18゜好ましくは
約0.8から約1.5の範囲である。
The ratio of fine titanium dioxide powder without alumina treatment to the polymer binder (when dry) in the light shielding layer is such that the light shielding layer is non-porous to the extent that oxygen permeability is maintained and at the same time protein impermeability is maintained. (This is smaller than the average pore size in which a developing action or a metering action appears in the porous developing layer, and also includes micropores +1 that do not have an expanding action or a metering action.) can. Specifically, this is a ratio of about 0.6 to about 18 degrees, preferably about 0.8 to about 1. The range is 5.

光遮蔽層の乾爆厚さは約3pmから約30 pm。The dry explosion thickness of the light shielding layer is about 3 pm to about 30 pm.

好ましくは約5μmから約20μmの範囲である。Preferably it ranges from about 5 μm to about 20 μm.

試薬層と光遮蔽層との間、またはオキシダーゼ層が設け
られる場合には試薬層とオキシダーゼ層との間、オキシ
ダーゼ層と光遮蔽層との間には必要に応じて中間層を設
けることができる。中間層としては試薬層に用いるのと
同様な被膜形成能を有する親木性ポリマーの層を用いる
ことができる。中間層の厚さは約0.2#1.mから約
1opLm、好ましくは約0.5μmから約7μmの範
囲である。光遮蔽層と後述する多孔性展開層との間には
必要に応じて接着層を設けることができる。
An intermediate layer can be provided between the reagent layer and the light shielding layer, or between the reagent layer and the oxidase layer if an oxidase layer is provided, or between the oxidase layer and the light shielding layer, as necessary. . As the intermediate layer, a layer of a wood-philic polymer having the same film-forming ability as that used for the reagent layer can be used. The thickness of the intermediate layer is approximately 0.2#1. m to about 1 opLm, preferably about 0.5 μm to about 7 μm. An adhesive layer can be provided between the light shielding layer and the porous spreading layer described below, if necessary.

接着層としては試薬層に用いるのと同様な被膜形成能を
有し、水で湿潤しているとき、または水を含んで膨潤し
ているときに多孔性展開層を接着し・体化できる親水P
1ポリマーを用いることができる。接ri層の厚さは約
0.5μmから約20am、Dfましくは約1μmから
約lOμmの範囲である。中間層および接着層に用いら
れる代表的でIl’fましい親水性ポリマーはゼラチン
、ゼラチン誘導体、ポリアクリルアミド、ポリビニルア
ルコール1−がある。
The adhesive layer is a hydrophilic layer that has the same film-forming ability as that used for the reagent layer and can adhere and form a porous spreading layer when wet with water or swollen with water. P
1 polymer can be used. The thickness of the contact layer ranges from about 0.5 μm to about 20 am, Df, preferably from about 1 μm to about 10 μm. Typical and desirable hydrophilic polymers used in interlayers and adhesive layers include gelatin, gelatin derivatives, polyacrylamide, and polyvinyl alcohol.

試薬層、光遮蔽層、中間層、接着層、オキシダーゼ層が
設けられる場合にはオキシダーゼ層、および指示薬層に
は必要に応じて界面活性剤を含有させることができる。
When a reagent layer, a light shielding layer, an intermediate layer, an adhesive layer, and an oxidase layer are provided, the oxidase layer and indicator layer may contain a surfactant as necessary.

界面活性剤としてはノニオン界面活性剤、とくにオキシ
エチレンまたはオキシプロピレンツ、(が8〜15個連
なった鎖状構造を含むノニオン界面活性剤が好ましい。
The surfactant is preferably a nonionic surfactant, particularly a nonionic surfactant having a chain structure of 8 to 15 oxyethylene or oxypropylene.

これらの層にはこの他に必要に応じて硬化剤(架橋剤)
、柔軟化剤または可塑剤等の公知の添加剤を含有させる
ことができる。
In addition to this, a curing agent (crosslinking agent) is added to these layers as necessary.
, a softener, a plasticizer, and other known additives.

光遮蔽層の上に、直接または接着層を介して、多孔性展
開層または定面積多孔性層(パッチ)が設けられる。多
孔性114開層(以下、中に展開層ともいう。)として
は特公昭53−21677号。
A porous spreading layer or a constant area porous layer (patch) is provided on the light shielding layer, either directly or via an adhesive layer. For porous 114 open layer (hereinafter also referred to as "open layer"), Japanese Patent Publication No. 53-21677 is used.

特開昭55−c+og5czン−1特開昭58−123
458号等に記載の非出M、笠方的多孔性媒体層、特開
昭55−164356号、特開昭57−66359号等
に記載の織物11G開層、特開昭57=148250号
に記載のポリオレフィンポリマーフィラメントパルプを
含む紙からなる層などを用いることができる。定面積多
孔性層としては実開昭57−42951号等に記・11
(の多孔性素材がある。これらのうちでは1)(間層が
好ましく、またl5fc開層としてはメンブランフィル
タ一層(プランシュポリマー層)、ポリマービーズを水
で1彰潤しないポリマー接着剤で点接触状に接着してな
る三次元格子粒状構造物層、織物IJG開層間層ましい
。Ij?開層間層面積多孔性層は前述の品持、M″vに
記載の方法に従って39けることができる。
JP-A-55-c+og5cz-n-1 JP-A-58-123
458, etc., Kasakata porous media layer, woven fabric 11G open layer described in JP-A-55-164356, JP-A-57-66359, etc., JP-A-57-148250 A layer consisting of paper containing the polyolefin polymer filament pulp described, etc. can be used. As a constant area porous layer, it is described in Utility Model Application Publication No. 57-42951 etc. 11
Among these, 1) (interlayer) is preferable, and as a l5fc open layer, a single layer of membrane filter (planche polymer layer), polymer beads are glued with a polymer adhesive that does not wet with water. The three-dimensional lattice granular structure layer formed by contact bonding is preferably a woven IJG open interlayer. can.

多孔性展開層には必要に応じて界面活性剤、好ましくは
前述のノニオン界面活性剤を含イ■させることができる
。さらに多孔性11G開層には特公昭55−45599
号に記載のごとくコレステロールエステラーゼ等の酵素
を含む試薬の一部やpH緩衝剤を含イ1させることがで
きる。また、多孔性1+4開層にもアルミナ処理なしの
二酸化チタン微粉末を分散含有させることができる。
The porous spreading layer may contain a surfactant, preferably the above-mentioned nonionic surfactant, if necessary. Furthermore, for porous 11G open layer,
As described in No. 1, a part of a reagent containing an enzyme such as cholesterol esterase and a pH buffer can be included. Further, fine titanium dioxide powder without alumina treatment can be dispersed and contained in the porous 1+4 open layer.

本発明の多層分析要素には、少なくとも試薬層または試
薬層より」−側の(すなわち試薬層から見て支持体から
遠い側)いずれか一つの層(多孔性分く諸層または定面
積多孔性層をも含める)に、弗素陰イオンとの間に水に
難溶性の1i1(以下、難溶性F q4という)を形成
しうる陽イオンを含む化合物(以F、難溶性F塩形成化
合物という)を含有させることができる。ここで、水に
難溶性とは25℃における木100gに対する溶解度が
0゜2g以下であることを意味する。難溶性F塩形成性
化合物としては特願昭57−131750号明細占に記
載の難溶性F塩形成性化合物を用いることができる。難
溶性F塩形成性化合物に含まれる陽イオンとしてはCa
′およびMg2+はオキシダーゼやペルオキシダーゼ等
の酵素の安定化作用をも有するので好ましい陽イ才/で
ある。対陰イオンとしては低級脂肪族モノカルボン醇陰
イオン。
The multilayer analytical element of the present invention includes at least one reagent layer or one layer on the "-" side of the reagent layer (i.e., the side far from the support when viewed from the reagent layer) (a porous partition layer or a porous layer with a constant area porosity). A compound containing a cation that can form a poorly soluble Fq4 in water with a fluorine anion (including a layer) (hereinafter referred to as a poorly soluble F salt-forming compound) can be contained. Here, "poorly soluble in water" means that the solubility per 100 g of wood at 25° C. is 0.2 g or less. As the poorly soluble F salt forming compound, the poorly soluble F salt forming compound described in Japanese Patent Application No. 57-131750 can be used. The cation contained in the poorly soluble F salt-forming compound is Ca.
' and Mg2+ are preferred since they also have a stabilizing effect on enzymes such as oxidase and peroxidase. The counter anion is a lower aliphatic monocarboxylic anion.

低級脂肪族ジカルホン酸陰イオン、ヒドロキシカルボン
酸陰イオン、ハロゲン陰イオン、燐耐陰イオン等がl+
rましい。難溶MF11!形成に1化合物としては酢酸
力ルシウJ・が好ましい。難溶+l F塩形成性化合物
は、多孔性展開層、定面積多孔Pi層、接着層、光遮蔽
層、試薬層、オキシダーゼ層が設けられる場合にはオキ
シダーゼ層、中間層等のうちの少なくともいずれか−・
層に含有させることができ、接着層、光遮蔽層、オキシ
ダーゼ層のいずれか一層または複数の層に含有させるこ
とか好ましい。難溶性F II形成性化合物の含有11
1は多層分析要素1rrfにつき0.1meqからle
q、好ましくは0.2me qから0.5eqの範囲で
ある。
Lower aliphatic dicarboxylic acid anions, hydroxycarboxylic acid anions, halogen anions, phosphorus-resistant anions, etc.
It's so sad. Hardly soluble MF11! As one compound for the formation, acetate chloride J. is preferred. The hardly soluble +l F salt-forming compound is a porous spreading layer, a constant area porous Pi layer, an adhesive layer, a light shielding layer, a reagent layer, and when an oxidase layer is provided, the oxidase layer, an intermediate layer, etc. Or...
It is preferable to include it in one or more of the adhesive layer, light shielding layer, and oxidase layer. Containing poorly soluble F II forming compound 11
1 is 0.1meq to le per multilayer analysis element 1rrf
q, preferably in the range of 0.2 meq to 0.5 eq.

特願昭57−131750−;明細−7に記載の方法に
従って、難溶性F塩形成性化合物を特定の層の塗布液に
溶解または分散させて塗布するか、あるいは接着層に多
孔性展開層を積層する際に接着層に供給する湿し木に難
溶性F j1形成性化合物を溶解させ、その湿し水を接
着層に供給することにより多層化’7分析材料に難溶性
F塩形成性化合物を含イ夏させることがせきる。
Japanese Patent Application No. 57-131750-; According to the method described in Specification 7, a poorly soluble F salt-forming compound is dissolved or dispersed in a coating solution for a specific layer and applied, or a porous spreading layer is applied to the adhesive layer. By dissolving a sparingly soluble F j1-forming compound in the dampening wood supplied to the adhesive layer during lamination, and supplying the dampening water to the adhesive layer, the sparingly soluble F salt-forming compound is added to the multilayered '7 analysis material. It can be used in summer.

難溶+l: ’F 塩形成P1化合物を含有させた本発
明の多層化学分析材料においては、血液試料の弗化物の
含イj :H:(N a Fに換算してOから約t5m
g/ml血液試料の範囲)にかかわりなく、弗化物不含
の面液試ネ゛lの場合と実質的に同じ被検物質測定イf
iが得られるほどに弗化物による妨害(または干渉)作
用がD1除されるので、難溶性F塩形成性化合物を含イ
1する態様は本発明の極めて好ましい態様の−・つであ
る。
In the multilayer chemical analysis material of the present invention containing a poorly soluble +l:'F salt-forming P1 compound, the fluoride content of the blood sample is approximately t5m from O in terms of NaF.
g/ml blood sample range), virtually the same analyte measurement efficiency as with fluoride-free surface fluid samples.
The more that i is obtained, the more the interference (or interference) effect by fluoride is divided by D1, so the embodiment containing the poorly soluble F salt-forming compound is an extremely preferred embodiment of the present invention.

前述の諸層を積層一体化して調製された一体型多層化学
分析要素は適宜なサイズに裁断され、特開昭54−15
6079号、実開昭56−142454号、特開昭57
−63452号、特表昭58−50114’4号、実開
昭58−32350号等に記載のスライド枠に収容して
分析スライドとして用いるのが便利である。この他に多
層分析要素は長テープ状や裁断片をアパーチュアカード
等に貼(ツまたははめこんで用いることもできる。
The integrated multilayer chemical analysis element prepared by laminating and integrating the above-mentioned layers was cut into an appropriate size, and
No. 6079, Utility Model Publication No. 142454, 1983, Japanese Patent Application Publication No. 1983
It is convenient to use it as an analysis slide by storing it in the slide frame described in Japanese Patent Publication No. 58-50114'4, Japanese Utility Model Application Publication No. 58-32350, etc. In addition, the multilayer analysis element can also be used in the form of a long tape or by being attached to an aperture card or the like.

なお、ここまでの説明ではすべての層が接着されている
一体型多層化学分析質素について説明したが、本発明は
これに限定されることなく、いずれかの層が接着されて
いがい多層化学分析要素にも適用することができる。
Although the explanation so far has been about an integrated multilayer chemical analysis element in which all layers are bonded, the present invention is not limited to this, and the present invention is not limited to this, but can be applied to an integrated multilayer chemical analysis element in which any of the layers are bonded. It can also be applied to

本発明の多層分析要素を用いてmI述の品持訂。Quality revision of mI description using the multilayer analysis element of the present invention.

およびrcIinical ChemistryJ 、
 24(8) 、+335−1342(+!37!])
l’$に記載の方1ノ、により主として比色分析/、l
:の原理により水性液体試才l中の被検物質の定量分析
を実施できる。
and rcIinical ChemistryJ,
24 (8), +335-1342 (+!37!])
Mainly based on colorimetric analysis/, l
Quantitative analysis of a test substance in an aqueous liquid sample can be carried out using the following principle.

本発明の多層化学分析要素には酵素が含有されるので、
分析を実施するに当っては25°Cから45°C1好ま
しくは30°Cから40’Cの範囲の温度で3分から3
0分、好ましくは4分から15分間インクベーションし
た後に比色分析する方Jノ。
Since the multilayer chemical analysis element of the present invention contains an enzyme,
When carrying out the analysis, the temperature range is 25°C to 45°C, preferably 30°C to 40'C, for 3 minutes to 30°C.
For those who perform colorimetric analysis after incubation for 0 minutes, preferably 4 to 15 minutes.

(end point法)か5才たはインクヘーパ/ヨ
ン温度は同じで反応の誘導期が経過した後に一定の時間
間隔で2回以」ニル色測定する方i1J:(rate法
)のいずれの方法でも実施することができる。
(end point method) or 5 years old or 5 years old or 2 times or more at a fixed time interval after the induction period of the reaction at the same temperature.I1J: (rate method) It can be implemented.

以下の実施例により本発明を具体的に説明する。The present invention will be specifically explained by the following examples.

[参考例1] (A)A見203で表面処理した二酸化チタン微粉末、
(B)A文203・5i02の混合酸化物で表面処理し
た二酸化チタン微粉末、および(C)表面処理されてい
ない二酸化チタン微粉末のそれぞれ5gを水40m1に
分散した後、それぞれにNaFを1g加えてさらにポリ
テトラフルオロエチレン被Ygシた攪拌林で攪拌し、つ
いで1時間数tしたときの分散液のp 、H値を測定し
たところ、第1表の結果かえられた。なお、ブランクと
して二酸化チタン微粉末を加えないで同じ操作を実施し
た。
[Reference Example 1] (A) Titanium dioxide fine powder surface-treated with A-203,
After dispersing 5 g of each of (B) fine titanium dioxide powder surface-treated with the mixed oxide of A 203/5i02 and (C) fine titanium dioxide powder without surface treatment in 40 ml of water, 1 g of NaF was added to each. In addition, the dispersion was further stirred in a stirring forest coated with Yg polytetrafluoroethylene, and after several hours had passed, the p and H values of the dispersion were measured, and the results shown in Table 1 were obtained. Note that the same operation was performed as a blank without adding fine titanium dioxide powder.

1ノ、(::r< 白 第1表 T i O2微 アナターゼ ルチル 加えず粉末結晶
型(0,15〜 (020〜 (ブラ(粒子径) 0.
25km ) 0.35壓m) ンク)表面処理 AC
AB − pH値 11.5 8.4 11.7 11.3 8.
0第1表の結果から、A立203、A文203・S i
 O2いずれかで表面処理された二酸化チタン微粉末水
分散液のpH値は著しく高くなるが、表面処理なしの二
酸化チタン微粉末水分散液のpH値はブランクとあまり
変らないpH値に留まっていることが明らかである。
1 no, (::r< White Table 1 T i O2 fine anatase rutile without addition powder crystal form (0.15 ~ (020 ~ (bura (particle size) 0.
25km) 0.35cm) Surface treatment AC
AB - pH value 11.5 8.4 11.7 11.3 8.
0 From the results in Table 1, A standing 203, A writing 203・S i
The pH value of the titanium dioxide fine powder aqueous dispersion that has been surface-treated with either O2 becomes significantly higher, but the pH value of the titanium dioxide fine powder aqueous dispersion without surface treatment remains at a pH value that is not much different from the blank. That is clear.

[参考例2] AJlzOa (アルミナ)表面処理二酸化チタン微粒
子(アナターゼ型1粒イサイズ0.15〜0.25μm
)および表面処理なし二酸化チタン微粒子(アナターゼ
型1粒子サイズ0.15〜0.25gm)それぞれ10
重量部、ゼラチン1屯j一部、および水20重量部を混
合、分散して調製した分散液をゼラチン下塗りが施され
た厚さ180ILmのポリエチレンテレフタレー) (
PET)フィルムの」二に乾燥層厚が5JLmになるよ
うに塗布し乾燥して2種の二酸化チタン/ゼラチン塗布
Ilりを調製した。それぞれの塗布膜の上に第2表に示
すNaF含有含有水溶液およびNaF不含の木(ブラン
ク)の1OJL文ずつを点着して塗布膜に吸収させ、密
閉箱中で25℃で5分放置し。
[Reference Example 2] AJlzOa (alumina) surface-treated titanium dioxide fine particles (anatase type, size 0.15 to 0.25 μm)
) and titanium dioxide fine particles without surface treatment (anatase type 1 particle size 0.15-0.25 gm) 10 each
A dispersion prepared by mixing and dispersing 1 ton of gelatin, 1 ton of gelatin, and 20 parts by weight of polyethylene terephthalate with a thickness of 180 ILm and undercoated with gelatin) (
Two types of titanium dioxide/gelatin coatings were prepared by coating the film to a dry layer thickness of 5 JLm and drying. 1 OJL of NaF-containing aqueous solution and NaF-free wood (blank) shown in Table 2 were spotted on each coating film, absorbed into the coating film, and left at 25°C for 5 minutes in a sealed box. death.

直ちに表面pH測定用電極(東亜電波工業■製:G5−
165F)を塗布膜におしあてて湿潤している塗布膜の
表面のpH値を測定し、第2表に示す結果を得た。
Electrode for surface pH measurement immediately (manufactured by Toa Denpa Kogyo ■: G5-
165F) was applied to the coating film and the pH value of the wet surface of the coating film was measured, and the results shown in Table 2 were obtained.

以下余白 第2表 湿潤塗布11りの表面のpHイf1 水溶液(7)NaF O5101520含有1ij(ブ
ランク) (mg/l水) アルミナ表面 処理TiO27,48,08,79,29,8表面処理
なし TiO27,47,47,47,57,8表面処理なし
の二酸化チタン微粉末/ゼラチン塗布膜においてはNa
F水溶液のNaF含有jlVの増加につれての塗布膜の
pH値の]ニガはわずかであり、特に血液試料に−・競
゛的に加えられる範囲であるNaF含イfi、jO−1
0m g / m lの範囲内ではpH値の変化は見ら
れないという特徴がある。
Table 2 below is the margin pH of the surface of wet application 11 Aqueous solution (7) NaF O5101520 containing 1ij (blank) (mg/l water) Alumina surface treatment TiO27, 48, 08, 79, 29, 8 No surface treatment TiO27 , 47, 47, 47, 57, 8 In titanium dioxide fine powder/gelatin coated film without surface treatment, Na
The pH value of the coated film as the NaF content of the F aqueous solution increases is small, especially when the NaF content is competitively added to blood samples.
It has the characteristic that no change in pH value is observed within the range of 0 mg/ml.

一方、アルミナ表面処理二酪化チタン/ゼラチン塗/I
t lりではNaF含有ti1.の増加につれて塗布膜
のpHイfi (1) I: ′j/が勇しく、NaF
含右含有〜10m g / m文の範囲内でのpH値の
」ニガが著しい。
On the other hand, alumina surface treatment titanium dibutyride/gelatin coating/I
In tl, NaF-containing ti1. As the pH of the coating film increases, the pH of the coating film (1) I: 'j/ becomes stronger, and NaF
Contains a significant amount of "niga" with a pH value within the range of ~10 mg/m.

[実施例1] ゼラチン下塗りが施されている厚さ180gmの無色透
明ポリエチレンテレフタレー) (PET)(i屑フイ
ルムの上に下記組成のグルコース測定用試薬層を乾燥層
厚が約151Lmになるようにり、て水溶液を用いて塗
布し乾燥して設けた。
[Example 1] A reagent layer for glucose measurement having the following composition was placed on a colorless transparent polyethylene terephthalate (PET) (i) scrap film with a thickness of 180 gm and coated with gelatin so that the dry layer thickness was approximately 151 Lm. It was coated using an aqueous solution and dried.

ペルオキシダーゼ 25000IU グルコースオキシダーゼ 100OOIU1.7−シヒ
ドロキシナフタレン 5g4−アミノアンチピリン 5
g ゼラチン 200g ポリオキシエチレン ノニルフェニルエーテル 2g グルコース測定用試薬層の上に下記組成の酸素透過性蛋
白質不透過性光遮蔽層を乾燥厚さが約7pmになるよう
にして水分散液を用いて塗布し乾燥して設けた。
Peroxidase 25000IU Glucose oxidase 100OOIU 1.7-hydroxynaphthalene 5g 4-aminoantipyrine 5
g Gelatin 200g Polyoxyethylene nonyl phenyl ether 2g On top of the reagent layer for glucose measurement, apply an oxygen permeable protein impermeable light shielding layer having the following composition to a dry thickness of approximately 7 pm using an aqueous dispersion. It was dried and set aside.

表面処理なしの二煎化チタン微粉末 100g(アナタ
ーゼ型1粒子サイズ 0.15〜0.25gm) ゼラチン log 光遮蔽層の上に下記tA成の接着層を乾燥層厚が約2μ
mになるようにして水溶液を塗布し乾燥して設けた。
100g of bi-decorated titanium fine powder without surface treatment (anatase type 1 particle size 0.15-0.25gm) Gelatin log On top of the light shielding layer, apply an adhesive layer of the following tA composition to a dry layer thickness of approximately 2μ
An aqueous solution was coated so as to have a thickness of m and was dried.

ゼラチン 4g ポリオキシエチレン ノニルフェニルエーテル O,1g 次に接着層に約3og/m’の割合で水を全面に供給し
て湿潤させた、のち、綿100%のブロード織物(10
0双ブロード)を軒く圧力をかけてラミネートし、乾燥
させてグルコース定♀、用一体型多層化学分析要素を調
製した。
Gelatin 4 g Polyoxyethylene nonylphenyl ether O, 1 g Next, water was supplied to the entire surface of the adhesive layer at a rate of about 3 og/m' to moisten it, and then a 100% cotton broad fabric (10
An integrated multilayer chemical analysis element for glucose determination was prepared by laminating the sample (0 double broad) under extreme pressure and drying it.

[比較例1] 光遮蔽層に用いる二癩化チタン微粉末としてAl2O3
・S+02表面処理二酸化チタン微粉末(ルチル型1粒
子サイズ0.20−0.35gm)を用いたほかは実施
例1と同様にして比較用のグルコース定星用一体型多層
化学分析要素を調製した。
[Comparative Example 1] Al2O3 was used as the titanium dileprone fine powder used in the light shielding layer.
・An integrated multilayer chemical analysis element for glucose constant was prepared in the same manner as in Example 1 except that S+02 surface-treated titanium dioxide fine powder (rutile type 1 particle size 0.20-0.35 gm) was used. .

このようにして得られた本発明の、および比較用のグル
コース定着用一体型多層化学分析要素のそれぞれの展開
層に、第3表に示すNaF含有量の異なるヒト血g11
0p1を点着し、密閉容器の中に37℃で10分放置(
インクベーション)し、直ちに15!潤している展開層
表面のPH値をG5−165F表面PH電極を用いて測
定し、第3表に示す結果を得た。
Human blood g11 with different NaF contents shown in Table 3 was added to each developed layer of the integrated multilayer chemical analysis element for glucose fixation of the present invention and for comparison obtained in this manner.
Apply 0p1 and leave it in a sealed container at 37℃ for 10 minutes (
Inkvation) and immediately 15! The PH value of the moistened surface of the spreading layer was measured using a G5-165F surface PH electrode, and the results shown in Table 3 were obtained.

以下余白 第3表 湿潤展開層の表面のpH値 ヒト血漿の 0 5 +0 15 2ONaF含右;1
1(ブランク) (mg/ml水) 実施例1の 多層分析要素 5.765.90 5.!30 5.9
5 6.05(本発明) 比較例1の 多層分析要素 5.?fl 8.75 7.+5 7.
42 7.73表面処理なしの二M化チタン微粉末を含
む光遮蔽層を有する本発明のグルコース定♀、用多層分
析要素においては、血漿のNaF含有星の増加につれて
の展開層のpH値のJ: ′jlが少なく、特に血液試
料に加えられる範囲のNaF含有星である0〜10 m
 g / m文血漿の範囲内の場合の展開層のp H(
ftの1−’;Iはわずかである。一方、A交203・
5i02表面処理二酸化チタン微粉末を含む光遮蔽層を
41する比較例1のグルコース足動用多層分析要素にお
いては、血漿のNaF含有量増加につれてのIs<間層
のpH値の上昇が著しく、特にNaF含有星O〜10m
g/m文血漿の範囲内において!+<間層のpH値の」
ニガが著しく大きい。
Below is the margin Table 3 pH value of the surface of the wet spreading layer Human plasma 0 5 +0 15 2ONaF included; 1
1 (blank) (mg/ml water) Multilayer analytical element of Example 1 5.765.90 5. ! 30 5.9
5 6.05 (Invention) Multilayer analysis element of Comparative Example 1 5. ? fl 8.75 7. +5 7.
42 7.73 In the multilayer analytical element for glucose determination ♀ of the present invention having a light shielding layer containing fine titanium diMide powder without surface treatment, the pH value of the developed layer increases as the NaF-containing stars in plasma increase. J: 0-10 m, which is a NaF-bearing star with low ′jl, especially in the range added to blood samples.
The pH of the developing layer in the range of g/m plasma (
1-' of ft; I is small. On the other hand, A intersection 203・
In the multilayer analytical element for glucose foot movement of Comparative Example 1, which has 41 light shielding layers containing 5i02 surface-treated titanium dioxide fine powder, the pH value of the Is<interlayer increases markedly as the NaF content of plasma increases. Containing star O~10m
Within the range of g/m plasma! +<pH value of interlayer」
The nigga is noticeably larger.

[実施例2] 接着層の組成として下記の組成を採用したほかは実施例
1と同様にしてグルコース定ダ用一体型多層分析黄素を
調製した。
[Example 2] An integrated multilayer analytical yellow for a glucose constant was prepared in the same manner as in Example 1 except that the following composition was adopted as the composition of the adhesive layer.

ゼラチン 4g 酎耐耐ルシウム 1.8g ポリオキシエチレン ノニルフェニルエーテル 0.1g [比較例2] 光遮蔽層に用いる二酸化チタン微粉末としてA1203
・5i02表面処理二酸化チタン微粉末(ルチル型、粒
子サイズ0.20−0.35μm)を用い、接着層の組
成を実施例2の接着層の組成と同じものを用いたほかは
実施例工と同様にして比較用グルコース定;l!用一体
型多層化学分析要素を調製した。
Gelatin 4g Lucium resistant 1.8g Polyoxyethylene nonylphenyl ether 0.1g [Comparative Example 2] A1203 as titanium dioxide fine powder used in the light shielding layer
・5i02 surface treatment Titanium dioxide fine powder (rutile type, particle size 0.20-0.35 μm) was used, and the composition of the adhesive layer was the same as that of Example 2. Glucose determination for comparison in the same manner; l! An integrated multilayer chemical analysis element was prepared.

このようにして調製した2種の要素をそれぞれ15mm
X 15mmの正方形のチップに裁断し、特開昭57−
63452号−に開示のプラスチ、ンクマウントに収め
てグルコース定rt用化学分析スライド(それぞれ本発
明の化学分析スライド、比較用化学分析スライドと名づ
ける)を調製した。
The two types of elements thus prepared were each 15 mm thick.
Cut into square chips of x 15mm, JP-A-57-
A chemical analysis slide for glucose determination RT (named the chemical analysis slide of the present invention and the chemical analysis slide for comparison, respectively) was prepared by placing the slide in a plastinum mount disclosed in No. 63452.

2種の化学分析スライISそれぞれの展開層に14表に
示すNaF含イ〕星の異なるヒト血漿10JL文を点着
し、密閉容器の中に37°Cで6分放置(インクベーシ
ョン)シ、直ちに、湿潤している展開層の表面のpH値
をG5−165F表面pH電極を用いて測定し、第4表
に示す結果を得た。
On the developed layer of each of the two types of chemical analysis slide IS, 10 JL of human plasma with different stars as shown in Table 14 was spotted, and left in a sealed container at 37°C for 6 minutes (incubation). Immediately, the pH value of the wetted surface of the spreading layer was measured using a G5-165F surface pH electrode, and the results shown in Table 4 were obtained.

また同じ血漿LOIi、lを点着した2種の化学分析ス
ライドについて37℃6分のインクベーションがなされ
る化学分析装置を用い、PETフィルム側から中心波長
500nmのIt丁視光で反射測光し、比色法により血
漿のグルコース含有Jaを測定して第4表に示す結果を
得た。
In addition, using a chemical analyzer capable of incubation at 37°C for 6 minutes on two types of chemical analysis slides on which the same plasma LOI, LOI was spotted, reflection photometry was performed from the PET film side using It optical light with a center wavelength of 500 nm. Glucose-containing Ja in plasma was measured by a colorimetric method, and the results shown in Table 4 were obtained.

第4表 ヒ ト 血 +1梵 の 0 5 10 158aF含
有lit、 (ブランク) (mg/ml血漿) 本発明の化学 ノ)枦スライド Jl(間層のpH値 6.40 8.42 fl、39
 fl、41グルコ一スl=度 測定値(mg/dl) +01 101 100 !比
較用の化学 ノ)析スライド 展開層のpH値 B、40 8.49 7.32 7.
71グルコ一ス濃度 測定イ〆n(IIg/dl) 102 10!li t
all 112表面処理なしの二酸化チタン微粉末含有
光遮蔽層を有する本発明のグルコース足H,1用化学分
析スライドの場合には、血漿に含イ1されるNaFへi
にかかわりなく実質的に同じグルコース含イf :j 
(A11l定価)が11tられる。一方、A文203φ
S i O2表面処理二酸化チタン微粉末含有光遮蔽層
を右する比較用グルコース定t、1用化学分析スライド
の場合には血漿中のNaFに起因する[浮(妨−i、0
が現れ、特にNaF含有1墨iが5 m g / m交
血漿をこえる範囲で干渉(妨害)か茗しい。
Table 4 Human blood +1 0 5 10 158aF-containing lit, (blank) (mg/ml plasma) Chemistry of the present invention) Slide Jl (interlayer pH value 6.40 8.42 fl, 39
fl, 41 glucose l=degree measurement value (mg/dl) +01 101 100! pH value of chemical analysis slide development layer for comparison B, 40 8.49 7.32 7.
71 Glucose concentration measurement (IIg/dl) 102 10! lit
All 112 In the case of the chemical analysis slide for glucose foot H,1 of the present invention having a light shielding layer containing titanium dioxide fine powder without surface treatment, the i
Substantially the same glucose content f:j
(A11l list price) is 11t. On the other hand, A sentence 203φ
In the case of a chemical analysis slide for comparative glucose measurement using a light shielding layer containing SiO2 surface-treated titanium dioxide fine powder, the
Interference (obstruction) appears, especially in the range where NaF-containing 1 ink i exceeds 5 mg/m mixed plasma.

[実施例3] ゼラチン下塗りが施されているJlさ180μmの無色
透明ポリエチレンテレフタレート(PET)平滑フィル
ムの−にに下記組成の指示薬層を乾燥層厚が約15pL
mになるようにして水溶液を用いて塗布し乾燥して設け
た。
[Example 3] An indicator layer having the following composition was applied to a colorless transparent polyethylene terephthalate (PET) smooth film with a thickness of 180 μm and coated with gelatin to a dry layer thickness of about 15 pL.
It was coated using an aqueous solution so as to have a thickness of m and dried.

ペルオキシダーゼ 25000IU 1.7−シヒドロキシナフタレン 5g4−アミノアン
チピリン 5g ゼラチン 200g ポリオキシエチレン ノニルフェニルエーテル 2g 指小薬層の」−に下記組成のグルコースオキシターゼ層
を乾燥層厚が約2ルmになるようにして水溶液を用いて
塗布し乾燥して設けた。
Peroxidase 25,000 IU 1.7-hydroxynaphthalene 5 g 4-aminoantipyrine 5 g Gelatin 200 g Polyoxyethylene nonylphenyl ether 2 g A glucose oxidase layer with the following composition was added to the fingertip layer so that the dry layer thickness was about 2 m. It was coated using an aqueous solution and dried.

セラチン 4.6g グルコースオキシダーゼ 4000IU3.3−ジメチ
ルグルタル酸 0:1gポリオキシエチレン ノニルフェニルエーテル 0.1g グルコースオキシダーゼ層の上に下記組成の醜素透過性
蛋白質不透過性光遮蔽層を乾燥厚さが約7gmになるよ
うにして水分散液を用いて塗41シ乾繰して設けた。
Ceratin 4.6 g Glucose oxidase 4000 IU 3.3-Dimethylglutaric acid 0:1 g Polyoxyethylene nonylphenyl ether 0.1 g On top of the glucose oxidase layer, place a ugliness-permeable, protein-impermeable light-shielding layer with the following composition to a dry thickness. An aqueous dispersion was used to coat 41 coats to a weight of about 7 gm and dried.

表面処理なしの二酸化チタン微 100g粉末(アナタ
ーゼ型、粒子サ イズ0.15〜0.25ALm) ゼラチン 10g 光遮蔽層のにに下記組成の接着層を乾燥層厚が約2gm
なるようにして水溶液を塗布し乾燥して設けた。
100 g of fine titanium dioxide powder without surface treatment (anatase type, particle size 0.15-0.25 ALm) 10 g of gelatin Add an adhesive layer of the following composition to the light shielding layer to a dry layer thickness of approximately 2 gm.
The aqueous solution was applied and dried.

ゼラチン Jog 酢酎カルシウム 5g ポリオキシエチレン ノニルフェニルエーテル 0.1g 次に接着層に約30 g / m’の割合で水を仝而に
供給して湿潤させたのち、+%5i100%のブロード
織物(100双ブロード)をφV<正方をかけてラミネ
ートし、乾燥させてグルコース定:+1−. Jll一
体型多層化学分析要素を調製した。
Gelatin Jog Vinegar Calcium 5g Polyoxyethylene nonyl phenyl ether 0.1g Next, water was supplied to the adhesive layer at a rate of about 30 g/m' to moisten it, and then a +%5i 100% broad fabric ( 100 double broad) was laminated with φV<square, dried and glucose constant: +1-. A Jll-integrated multilayer chemical analysis element was prepared.

このようにして調製したグルコース定j番;用一体型多
層化学分析要素を用い、実施例2と同様のNaF含有含
有光なるヒト血漿および全血を用いてグルコース含有1
.1を測定したところ、実施例2と同様に血漿または全
血中に含有されるNaFにかかわりなく実質的に同じグ
ルコース含有’+i: (All定植)が得られた。
Using the integrated multilayer chemical analysis element for glucose constant prepared in this way, the same NaF-containing human plasma and whole blood as in Example 2 were used to analyze glucose
.. As in Example 2, substantially the same glucose content '+i: (All transplanted) was obtained regardless of the NaF contained in plasma or whole blood.

[実施例4] 光遮蔽層に加える二酸化チタン微粉末を表面処理なしの
ルチル型二酸化チタン微粉末(粒7−020〜0.35
pm)を用いたほかはそれぞれ実施例2および3と同様
にしてグルコース定量用一体型多層化学分析要素を調製
し、それぞれを実施例2と同様のNaF含有量の異なる
ヒト血漿を用いてグルコース含有量を測定したところ、
血漿中に含イIされるN a F 量にかかわりなく実
質的に同しグルコース含有量(測定値)が得られた。
[Example 4] Rutile-type titanium dioxide fine powder (particles 7-020 to 0.35) without surface treatment was used as titanium dioxide fine powder to be added to the light shielding layer.
An integrated multilayer chemical analysis element for glucose determination was prepared in the same manner as in Examples 2 and 3, except that pm) was used, and each was prepared using human plasma with different NaF contents as in Example 2. When we measured the amount,
Substantially the same glucose content (measured value) was obtained irrespective of the amount of N a F contained in the plasma.

Claims (4)

【特許請求の範囲】[Claims] (1)水不浸透性光透過性支持体の上に試薬層、光遮蔽
層、および多孔性展開層がこの順に設けられてなる多層
化学分析要素において、前記光遮蔽層に醇化アルミニウ
ムまたはアルミニウムの含水酸化物を含む物質による表
面処理がなされていない二酸化チタン微粉末または表面
処理されていない二酸化チタン微粉末が含有されている
ことを4¥徴とする多層化学分析要素。
(1) A multilayer chemical analysis element in which a reagent layer, a light-shielding layer, and a porous development layer are provided in this order on a water-impermeable, light-transmitting support, in which the light-shielding layer contains aluminum chloride or aluminum. A multilayer chemical analysis element characterized by ¥4 containing fine titanium dioxide powder that has not been surface-treated with a substance containing a hydrous oxide or fine titanium dioxide powder that has not been surface-treated.
(2)前記試薬層または前記試薬層より上側のいずれか
一つの層にオキシダーゼが含有されている特許請求の範
囲1に記載の多層化学分析要素。
(2) The multilayer chemical analysis element according to claim 1, wherein the reagent layer or any one layer above the reagent layer contains oxidase.
(3)前記試薬層にペルオキシダーゼと過醋化水素との
存在下で検出可能な変化を生ずる過酸化水素指示薬、お
よびペルオキシダーゼが含有されている特許請求のa1
71111または2に記載の多層化・γ・分析要ま。
(3) Claim a1, wherein the reagent layer contains a hydrogen peroxide indicator that causes a detectable change in the presence of peroxidase and hydrogen peroxide, and peroxidase.
71111 or 2, multilayering, γ, and analysis summary.
(4)前記試薬層または前記試薬層よりI−側のいずれ
か一つの層に、弗素陰イオンとの間に水に難溶性の塩を
形成しうる陽イオンを含む化合物が含有されている4N
訂請求の範囲1.2または3に記載の多層化学分析要素
(4) The reagent layer or any one layer on the I- side of the reagent layer contains a 4N compound containing a cation that can form a salt that is sparingly soluble in water with a fluorine anion.
The multilayer chemical analysis element according to claim 1.2 or 3.
JP58217428A 1983-11-18 1983-11-18 Multilayer chemical analysis element Pending JPS60108753A (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP58217428A JPS60108753A (en) 1983-11-18 1983-11-18 Multilayer chemical analysis element
DE8484113978T DE3485856T2 (en) 1983-11-18 1984-11-19 MULTILAYER CHEMICAL ANALYTICAL ELEMENT.
EP84113978A EP0142849B1 (en) 1983-11-18 1984-11-19 Multilayer chemical analytical element
US07/011,386 US4781890A (en) 1983-11-18 1987-02-05 Multilayer chemical analytical element

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP58217428A JPS60108753A (en) 1983-11-18 1983-11-18 Multilayer chemical analysis element

Publications (1)

Publication Number Publication Date
JPS60108753A true JPS60108753A (en) 1985-06-14

Family

ID=16704055

Family Applications (1)

Application Number Title Priority Date Filing Date
JP58217428A Pending JPS60108753A (en) 1983-11-18 1983-11-18 Multilayer chemical analysis element

Country Status (4)

Country Link
US (1) US4781890A (en)
EP (1) EP0142849B1 (en)
JP (1) JPS60108753A (en)
DE (1) DE3485856T2 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1992700A1 (en) 2007-05-16 2008-11-19 FUJIFILM Corporation Method for producing dry analytical element for pancreatic lipase measurement
EP2003450A1 (en) 2007-06-12 2008-12-17 Fujifilm Corporation Dry analytical element for lipase measurement
EP2105509A1 (en) 2008-03-25 2009-09-30 Fujifilm Corporation Multilayer dry analytical element for pancreatic lipase measurment
EP2105508A1 (en) 2008-03-25 2009-09-30 Fujifilm Corporation Dry analytical element for pancreatic lipase measurement

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6348457A (en) * 1986-08-19 1988-03-01 Fuji Photo Film Co Ltd Dry-type multi-layered analytical element
DE3783851T2 (en) * 1986-10-09 1993-06-17 Fuji Photo Film Co Ltd INTEGRAL, MULTILAYERED ELEMENT FOR ANALYSIS.
US5547874A (en) * 1986-10-31 1996-08-20 Fuji Photo Film Co., Ltd. Method for control or calibration in a chemical analytical determination
US5308767A (en) * 1986-10-31 1994-05-03 Fuji Photo Film Co., Ltd. Method for control or calibration in a chemical analytical determination
JPS63196849A (en) * 1987-02-12 1988-08-15 Fuji Photo Film Co Ltd Integration type multi-layer analysis element
US4937186A (en) * 1988-01-28 1990-06-26 Iqbal Siddiqi Method for the determination of bilirubin in solution
US5304467A (en) * 1988-11-30 1994-04-19 Kyoto Daiichi Kagaku Co., Ltd. Device for assay of liquid sample
DE4015590A1 (en) * 1990-05-15 1991-11-21 Boehringer Mannheim Gmbh TEST CARRIER FOR THE DETERMINATION OF IONS
IT1247946B (en) * 1991-05-17 1995-01-05 Instrumentation Lab Srl LIQUID STABILIZATION OF URATE OXIDASE ENZYME
US5286450A (en) * 1992-06-01 1994-02-15 Eastman Kodak Company Bilirubin assay using crosslinkable polymers
US5358852A (en) * 1992-12-21 1994-10-25 Eastman Kodak Company Use of calcium in immunoassay for measurement of C-reactive protein
US5416004A (en) * 1993-01-19 1995-05-16 Detwiler; Richard L. Multilayer analytical element containing primary amine buffer and method for the determination of ethanol
WO1995000662A1 (en) * 1993-06-21 1995-01-05 Boehringer Mannheim Corporation Diagnostic reagent stabilizer
GB2321967B (en) * 1996-11-08 2001-05-02 Mercury Diagnostics Inc Opaque reaction matrix for the analysis of whole blood
US6703247B1 (en) * 1996-12-23 2004-03-09 American Registry Of Pathology Apparatus and methods for efficient processing of biological samples on slides
US6306347B1 (en) 1998-01-21 2001-10-23 Bayer Corporation Optical sensor and method of operation
US6190612B1 (en) 1998-01-21 2001-02-20 Bayer Corporation Oxygen sensing membranes and methods of making same
US6254831B1 (en) 1998-01-21 2001-07-03 Bayer Corporation Optical sensors with reflective materials
AU3439999A (en) 1998-05-13 1999-11-29 Bayer Corporation Sample introduction device
US6100005A (en) * 1998-05-29 2000-08-08 Polaroid Corporation Photographic element and method
US6107083A (en) * 1998-08-21 2000-08-22 Bayer Corporation Optical oxidative enzyme-based sensors
US6207110B1 (en) 1998-08-21 2001-03-27 Bayer Corporation Metallic overcoating as a light attenuating layer for optical sensors
US7157056B2 (en) * 1999-05-12 2007-01-02 Bayer Corporation Sample introduction device
JP3910102B2 (en) * 2002-04-25 2007-04-25 富士フイルム株式会社 Dry analysis element and analysis kit
US7449146B2 (en) * 2002-09-30 2008-11-11 3M Innovative Properties Company Colorimetric sensor
US20040062682A1 (en) * 2002-09-30 2004-04-01 Rakow Neal Anthony Colorimetric sensor
BRPI0518883A2 (en) 2004-12-13 2008-12-16 Bayer Healthcare Llc self-limiting size compositions and test devices for measuring analytes in biological fluids
CN101223284A (en) * 2005-05-17 2008-07-16 雷迪奥米特医学公司 Enzyme sensor including a water-containing spacer layer
EP1889075B1 (en) * 2005-05-17 2013-07-17 Radiometer Medical ApS Method of stabilising or reactivating a creatinine sensor with a solution of a divalent manganese ion
US7767143B2 (en) * 2006-06-27 2010-08-03 3M Innovative Properties Company Colorimetric sensors
AU2008222860B2 (en) * 2007-03-05 2013-10-31 Advanced Liquid Logic, Inc. Hydrogen peroxide droplet-based assays
US8471283B2 (en) * 2008-02-25 2013-06-25 Kabushiki Kaisha Toshiba White LED lamp, backlight, light emitting device, display device and illumination device
EP2366102B1 (en) * 2008-11-07 2019-11-06 Roche Diabetes Care GmbH Device and method for detecting an analyte in a sample

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5728277A (en) * 1980-07-28 1982-02-15 Aloka Co Ltd Radiation detector
JPS58131565A (en) * 1982-01-14 1983-08-05 Konishiroku Photo Ind Co Ltd Analysing element

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3992158A (en) * 1973-08-16 1976-11-16 Eastman Kodak Company Integral analytical element
US4166763A (en) * 1976-12-10 1979-09-04 Eastman Kodak Company Analysis of lactic acid or lactate using lactate oxidase
US4098574A (en) * 1977-08-01 1978-07-04 Eastman Kodak Company Glucose detection system free from fluoride-ion interference
US4255384A (en) * 1978-08-14 1981-03-10 Fuji Photo Film Co., Ltd. Multilayered integral element for the chemical analysis of the blood
JPS5920853A (en) * 1982-07-28 1984-02-02 Fuji Photo Film Co Ltd Multi-layer analysis material
JPS5954962A (en) * 1982-09-22 1984-03-29 Fuji Photo Film Co Ltd Multilayer assay material
JPS59193352A (en) * 1983-04-18 1984-11-01 Fuji Photo Film Co Ltd Reagent for analysis, method of analysis and element of multiple chemical analysis
JPS6082859A (en) * 1983-10-13 1985-05-11 Fuji Photo Film Co Ltd Integral type multi-layered chemical analysis element

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5728277A (en) * 1980-07-28 1982-02-15 Aloka Co Ltd Radiation detector
JPS58131565A (en) * 1982-01-14 1983-08-05 Konishiroku Photo Ind Co Ltd Analysing element

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1992700A1 (en) 2007-05-16 2008-11-19 FUJIFILM Corporation Method for producing dry analytical element for pancreatic lipase measurement
EP2003450A1 (en) 2007-06-12 2008-12-17 Fujifilm Corporation Dry analytical element for lipase measurement
EP2105509A1 (en) 2008-03-25 2009-09-30 Fujifilm Corporation Multilayer dry analytical element for pancreatic lipase measurment
EP2105508A1 (en) 2008-03-25 2009-09-30 Fujifilm Corporation Dry analytical element for pancreatic lipase measurement

Also Published As

Publication number Publication date
DE3485856T2 (en) 1993-01-14
EP0142849B1 (en) 1992-08-05
US4781890A (en) 1988-11-01
DE3485856D1 (en) 1992-09-10
EP0142849A2 (en) 1985-05-29
EP0142849A3 (en) 1987-04-15

Similar Documents

Publication Publication Date Title
JPS60108753A (en) Multilayer chemical analysis element
US4098574A (en) Glucose detection system free from fluoride-ion interference
EP0382207B1 (en) Analytical element for whole blood
CN1394281A (en) Reagent test strip for analyte determination
JPH0726959B2 (en) Whole blood analysis element
JPS61245057A (en) Integral type multi-layered analyzing element
JPH0550275B2 (en)
JP2611890B2 (en) Measurement method using dry analytical element and dry analytical element
JPH0580049A (en) Measuring method using dry type analysis element and dry type analysis element
CA1226796A (en) Reflective particle-containing analytical element
EP0137521B1 (en) Integral multilayer element for chemical analysis
US5118472A (en) Analytical element for analysis of whole blood
JPS6211167A (en) Multilayered analytical element for analyzing cholesterol
US5589347A (en) Multilayer analysis elements for the determination of total cholesterol
US5496708A (en) Reagent composition for quantitative analysis of inorganic phosphorous and dry analysis element utilizing the same
JPS63196849A (en) Integration type multi-layer analysis element
JP4003993B2 (en) Method for producing dry analytical element and dry analytical element
EP0272578B1 (en) Multilayer analysis elements for the determination of total cholesterol
JPH0579319B2 (en)
JPH0394698A (en) Integrated multi-layer analytic element containing ammonia determination reagent composition
JPS62205798A (en) Analytical element for determination of lactic acid dehydrogenase activity
JPH07191020A (en) Method for analyzing whole-blood sample using whole-blood analyzing element
JPS6239773A (en) Monolithic multilayered analytical element for analyzing bilirubin
JPS63219400A (en) Integral multilayer analytical element for urea analysis
JPS63258600A (en) Integrated multi-layer analytic element for determination of total cholesterol